- call +1-201-465-4211
- email sales@mrinsights.biz
According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose.
Scope of the Report:
This report focuses on the Human Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
A major trend being witnessed in the global human vaccines market is the increase in strategic alliances. Increase in threat from regional vendors in developing countries may cause price erosion and may compel major players to operate under low-margin models. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company.
The growth of the global human vaccines market is driven by the inclusion of several pediatric vaccines in the national immunization schedule of various countries. This helps in increasing the consumption of vaccines. Similarly, the increase in the prevalence of infectious diseases and cancers is also leading to market growth.
The worldwide market for Human Vaccine is expected to grow at a CAGR of roughly 9.8% over the next five years, will reach 24600 million US$ in 2023, from 14100 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Bavarian Nordic
Baxter
Bharat Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Conjugate
Recombinant
Inactivated
Combination
Attenuated
Others
Market Segment by Applications, can be divided into
Pediatrics
Adolescents
Adults
Geriatrics
There are 15 Chapters to deeply display the global Human Vaccine market.
Chapter 1, to describe Human Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Vaccine, with sales, revenue, and price of Human Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Human Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Conjugate
1.2.2 Recombinant
1.2.3 Inactivated
1.2.4 Combination
1.2.5 Attenuated
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Pediatrics
1.3.2 Adolescents
1.3.3 Adults
1.3.4 Geriatrics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Human Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Human Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Human Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Human Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Human Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bavarian Nordic
2.6.1 Business Overview
2.6.2 Human Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bavarian Nordic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Baxter
2.7.1 Business Overview
2.7.2 Human Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Baxter Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bharat Biotech
2.8.1 Business Overview
2.8.2 Human Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bharat Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Human Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Human Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Human Vaccine Market Analysis by Regions
4.1 Global Human Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Human Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Human Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Human Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Human Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Human Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Vaccine Sales and Growth Rate (2013-2018)
5 North America Human Vaccine by Countries
5.1 North America Human Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Human Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Human Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Human Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Human Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Human Vaccine Sales and Growth Rate (2013-2018)
6 Europe Human Vaccine by Countries
6.1 Europe Human Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Human Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Human Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Human Vaccine Sales and Growth Rate (2013-2018)
6.4 France Human Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Human Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Human Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Human Vaccine by Countries
7.1 Asia-Pacific Human Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Human Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Human Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Human Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Human Vaccine Sales and Growth Rate (2013-2018)
7.5 India Human Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Human Vaccine Sales and Growth Rate (2013-2018)
8 South America Human Vaccine by Countries
8.1 South America Human Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Human Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Human Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Human Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Human Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Human Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Human Vaccine by Countries
9.1 Middle East and Africa Human Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Human Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Human Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Human Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Human Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Human Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Human Vaccine Sales and Growth Rate (2013-2018)
10 Global Human Vaccine Market Segment by Type
10.1 Global Human Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Conjugate Sales Growth and Price
10.2.1 Global Conjugate Sales Growth (2013-2018)
10.2.2 Global Conjugate Price (2013-2018)
10.3 Recombinant Sales Growth and Price
10.3.1 Global Recombinant Sales Growth (2013-2018)
10.3.2 Global Recombinant Price (2013-2018)
10.4 Inactivated Sales Growth and Price
10.4.1 Global Inactivated Sales Growth (2013-2018)
10.4.2 Global Inactivated Price (2013-2018)
10.5 Combination Sales Growth and Price
10.5.1 Global Combination Sales Growth (2013-2018)
10.5.2 Global Combination Price (2013-2018)
10.6 Attenuated Sales Growth and Price
10.6.1 Global Attenuated Sales Growth (2013-2018)
10.6.2 Global Attenuated Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Human Vaccine Market Segment by Application
11.1 Global Human Vaccine Sales Market Share by Application (2013-2018)
11.2 Pediatrics Sales Growth (2013-2018)
11.3 Adolescents Sales Growth (2013-2018)
11.4 Adults Sales Growth (2013-2018)
11.5 Geriatrics Sales Growth (2013-2018)
12 Human Vaccine Market Forecast (2018-2023)
12.1 Global Human Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Human Vaccine Market Forecast (2018-2023)
12.2.2 Europe Human Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Vaccine Market Forecast (2018-2023)
12.2.4 South America Human Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Vaccine Market Forecast (2018-2023)
12.3 Human Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Human Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Human Vaccine Market Share Forecast by Type (2018-2023)
12.4 Human Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Human Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Human Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Human Vaccine Picture
Table Product Specifications of Human Vaccine
Figure Global Sales Market Share of Human Vaccine by Types in 2017
Table Human Vacci
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
